Huda Al-Ghareeb* and Asma AlKandari

Assistant Undersecretary of Technical Affair, MOH Kuwait, Kuwait

*Corresponding Author: Huda Al-Ghareeb, Assistant Undersecretary of Technical Affair, MOH Kuwait, Kuwait.

Received: April 11, 2022; Published: May 10, 2022

Abstract

Objective: Discuss the importance of early transmission control at the onset of an epidemic with special reference to healthcare workers in Covid-19 centers.

Summarize the clinical characteristic if fined for Covid -19 patients attending the Covid -19 centers.

Discuss the implication for design of diagnostic strategies for HCWs at risk of COVID-19.

Aim: To assess the prevalence of asymptomatic individuals in this outbreak and to describe the clinical presentation of patients with mild and moderate Covid-19.

To estimate the asymptomatic ratio- the percentage of carriers with no symptoms will improve understanding of COVID-19 transmission and the spectrum of disease it causes, providing insight into epidemic spread.

Keywords: COVID-19; Outbreak; Kuwait

References

1. Giuseppe M and Fabio F. “Prevalence of Taste and smell dysfunction in coronavirus disease 2019”. JAMA Otolaryngology – Head and Neck Surgery 8 (2020): 1-6.
2. Daniel P Oran. “Prevalence of Asymptomatic SARS-CoV-2 infection”. Annals of Internal Medicine (2020).
3. Joseph T Wu., et al. “Now casting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study”. The Lancet 395 (2020): 689-697.
4. Jasper F., et al. “A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster”. The Lancet 395 (2020): 514-523.
5. Thirumalaisamy P and Christian G. “The COVID-19 epidemic”. Tropical Medicine and International Health, March 25 (2020): 278-280.
6. Jingjing H and Yifei G. “Proportion of asymptomatic coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis”. Journal of Medical Virology 93 (2021): 820-830.
7. Wei D and Xinmiao C. “Clinical Characteristics of Asymptomatic Patients with SARS-CoV-2 in Zhejiang: An Imperceptible Source of Infection”. Canadian Respiratory Journal (2020).
8. Khalid A and Abdullah O. “Clinical Presentation of Asymptomatic and Mild SARS-CoV-2 Infection in Riyadh, Saudi Arabia”. Journal of Multidisciplinary Healthcare 14 (2021): 1341-1347.
9. Chaolin H and Yeming W. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. The Lancet. January (2020).
10. AlJishi J and Alhajjaj A. “Clinical characteristics of asymptomatic and symptomatic COVID-19 patients in the Eastern Province of Saudi Arabia”. Journal of Infection and Public Health 14 (2021): 6-11.
11. Macarena G and Nikolay L. “Centers for Disease Control and Prevention 2019 novel coronavirus disease (COVID-19) information management: addressing national health-care and public health needs for standardized data definitions and codified vocabulary for data exchange”. Journal of the American Medical Informatics Association 9 (2020): 1476-1487.
12. Carlos D and Preeti N. “Covid-19 -New insights on a rapidly changing Epidemic”. JAMA Aprl 14, 323.14 (2020): 1339-1340.
13. Yandi Li and Jie Shi. “Asymptomatic and Symptomatic Patients With Non-severe Coronavirus Disease (COVID-19) Have Similar Clinical Features and Virological Courses: A Retrospective Single Center Study”. Frontiers in Microbiology 11 (2020).
14. Hiroshi N and Takeshi M. “Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)”. International Journal of Infectious Diseases 94 (2020): 154-155.
15. Emily A., et al. “Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science”. The Lancet Psychiatry 7 (2020): 547-560.
16. Gu Kim and MJ Kim. “Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19”. Clinical Microbiology and Infection 26 (2020): 948.e1e948.e3.
17. Zuin M and Gentili V. “Viral Load Difference between Symptomatic and Asymptomatic COVID-19 Patients: Systematic Review and Meta-Analysis”. Infectious Disease Reports 13 (2021): 645-653.
18. http://contagionlive.com. Looking at Asymptomatic Vs. Symptomatic COVID-19 Patients.
19. Nele V., et al. “Diagnosis of COVID-19 Based on Symptomatic Analysis of Hospital Healthcare Workers in Belgium: Observational Study in a Large Belgian Tertiary Care Center During Early COVID-19 Outbreak”. Occupational and Environmental Medicine1 (2021): 27-31.
20. “Clinical characteristics of COVID-19 in New York City”. The New England Journal of Medicine (2020).
21. Kenneth M and Martin S. “Coronavirus disease 2019 (COVID-19): Epidemiology, virology, and prevention” (2020).
22. Mei X and Zhang Y. “Observation about symptomatic and asymptomatic infections of 494 patients with Covid-19 in Shanghai, China”. American Journal of Infection Control 48 (2020): 1045-1050.
23. Grant MC., et al. “The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-Cov-2; Covid-19): a systematic review and meta-analysis of 148 studies from 9 countries”. Plos One 15 (2020).

Citation

Citation: Huda Al-Ghareeb and Asma AlKandari. “Covid-19 Infection Among Asymptomatic and Symptomatic Patients in Kuwait”.Acta Scientific Medical Sciences 6.6 (2022): 102-108.

Copyright

Copyright: © 2022 Huda Al-Ghareeb and Asma AlKandari. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.